Sunday, June 03, 2012

FDA Issues Warning About Counterfeit Adderall

The FDA has issued a warning about counterfeit generic Adderall tablets being sold on the web. Adderall is approved by the FDA to treat attention-deficit hyperactivity disorder and narcolepsy.

The FDA became aware of the problem when Teva Pharmaceutical Industries reported that a consumer alerted them about purchasing a fake version of Teva's Adderall 30-milligram tablets from an illegal Internet pharmaceutical site.
The bogus version was discovered "by a consumer, who noticed misspellings on on the fake product packaging," according to Denise Bradley, Teva Pharmacautical's vice president of corporate communications. Bradley said two incidents have been reported to the FDA, and Teva Pharmaceuticals continues to work with the FDA on the investigation.